ORPHAZYME A/S
Credit rating
Company information
About the company
ORPHAZYME A/S (CVR number: 32266355K) is a company from HERLEV. The company recorded a gross profit of 0 kDKK in 2023. The operating profit was -27 mDKK, while net earnings were -26 mDKK. The profitability of the company measured by Return on Assets (ROA) was -68.4 %, which can be considered poor and Return on Equity (ROE) was -94.3 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 73.7 %, a level that can be considered to be good. This shows that a large part of the company's assets are funded by shareholders' equity, reducing financial risk. ORPHAZYME A/S's liquidity measured by quick ratio was 3.8 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.
Financial information
See financialsGross profit (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Volume | |||||
Net sales | |||||
Gross profit | |||||
EBIT | - 335 954.00 | - 608 534.00 | -83 473.00 | -41 241.00 | -27 041.00 |
Net earnings | - 337 497.00 | - 633 246.00 | - 626 539.00 | 35 072.00 | -26 048.00 |
Shareholders equity total | 52 969.00 | 620 525.00 | 9 339.00 | 40 974.00 | 14 242.00 |
Balance sheet total (assets) | 822 493.00 | 173 229.00 | 56 826.00 | 19 312.00 | |
Net debt | - 123 588.00 | - 669 750.00 | -68 790.00 | -38 918.00 | -18 213.00 |
Profitability | |||||
EBIT-% | |||||
ROA | -73.7 % | -16.8 % | -35.7 % | -68.4 % | |
ROE | -637.2 % | -94.0 % | -198.9 % | 139.4 % | -94.3 % |
ROI | -633.6 % | -81.3 % | -21.7 % | -69.1 % | -94.2 % |
Economic value added (EVA) | - 310 732.96 | - 600 488.98 | 30 579.12 | 70 856.30 | 77 734.17 |
Solvency | |||||
Equity ratio | 50.0 % | 75.4 % | 5.4 % | 72.1 % | 73.7 % |
Gearing | 9.2 % | 358.3 % | |||
Relative net indebtedness % | |||||
Liquidity | |||||
Quick ratio | 4.7 | 1.2 | 3.6 | 3.8 | |
Current ratio | 4.7 | 1.2 | 3.6 | 3.8 | |
Cash and cash equivalents | 123 588.00 | 726 929.00 | 102 255.00 | 38 918.00 | 18 213.00 |
Capital use efficiency | |||||
Trade debtors turnover (days) | |||||
Net working capital % | |||||
Credit risk | |||||
Credit rating | B | BB | BB | B | B |
Variable visualization
Roles
Companies in the same industry
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.